# Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)Subjects

> **NCT00158873** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 224 (—)

## Conditions studied

- Sedation

## Interventions

- **DRUG:** midazolam
- **DRUG:** lorazepam
- **DRUG:** fentanyl
- **DRUG:** morphine
- **DRUG:** remifentanil
- **DRUG:** propofol

## Key facts

- **NCT ID:** NCT00158873
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 224 (—)
- **Last updated:** 2008-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00158873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00158873, "Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)Subjects". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT00158873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*